Document:

Addendum to Employment Offer Letter

 Exhibit 10.19 
  

					
	

	 		  	Metabasis Therapeutics, Inc.
	 		  	11119 North Torrey Pines Road
	 		  	La Jolla, California 92037
	September 12, 2006	 		  	  
 T 858 587 2770   F 858 458 3504

		 		  	www.mbsis.com

 Barry Gumbiner, M.D. 
 221 Coldspring Court 
 Franklin Township, NJ 08873 
 Dear Barry: 
 The purpose of this letter is to provide you with an addendum to the terms set forth in your offer letter dated September 6,
2006. In addition to the offer of employment with the same benefits and policy guidelines set forth in your original offer letter, the following terms will be added. 
 In addition to the relocation summary, Metabasis will agree to pay up to 2 trips to New Jersey to oversee the sale and close of your home and move of your household goods. In addition, we will pay for your rental car
while in New Jersey and from the time you arrive in San Diego until your own automobile is delivered. 
 Per your professional expenses, Metabasis will pay
your membership in at least three professional societies of your choice. Metabasis will also pay for up to 2 state medical licenses. Additionally, Metabasis agrees to let you take up to one half day of each week to work in a clinic and will pay for
your malpractice insurance if this is not provided by the clinic. 
 According to our current stock options guidelines, you will be eligible to receive up to
33,450 options each year based on your performance. Please find the Stock Option Agreement attached to this document. 
 To formally record your
acknowledgement of this addendum, please sign below and return one original of this letter to me as soon as possible. 
 Sincerely, 
 

 
 Howard Foyt, M.D., Ph.D. 
 Vice
President, Clinical Development 
  

					
	 

  
	 		  	 9-19-06

	Barry Gumbiner, M.D.	 		  	DateSeverance Agreement

 Exhibit 10.20 
 METABASIS THERAPEUTICS, INC. 
 SEVERANCE AGREEMENT 
 THIS SEVERANCE AGREEMENT (this “Agreement”) is entered into effective as of
June 18, 2007 (the “Effective Date”), by and between BARRY GUMBINER (the “Employee”) and METABASIS THERAPEUTICS,
INC., a Delaware corporation (the “Company”). 
 RECITALS 
 WHEREAS, the Employee and the Company entered into a Severance Agreement dated September 15, 2006 (the “Prior
Severance Agreement”); and 
 WHEREAS, the parties have agreed that the Prior Severance Agreement shall be
amended, restated and superseded as set forth herein. 
 AGREEMENT 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is acknowledged, it is
agreed between the parties as follows: 
 1. Term of Agreement. 
 This Agreement shall remain in effect from the Effective Date until the earlier of: 
 (a) The date when the Employee’s employment with the Company terminates for any reason not described in Section 6; or

 (b) The date when the Company has met all of its obligations under this Agreement following a termination of the
Employee’s employment with the Company for a reason described in Section 6. 
 2. Definition of Change in Control.

 For all purposes under this Agreement, “Change in Control” shall mean the occurrence of any of the following
events after the Effective Date: 
 (a) The Company is merged, consolidated, or reorganized into or with another legal
entity, and as a result of such merger, consolidation or reorganization more than 50% of the voting securities of such entity or its parent outstanding immediately after such transaction are held by persons other than the holders of voting
securities of the Company immediately prior to such transaction; 
 (b) The Company sells all or substantially all of
its assets to another legal entity and thereafter, more than 50% of the voting securities of such entity or its parent outstanding immediately after such transaction are held by persons other than the holders of voting securities of the Company
immediately prior to such transaction; 
  

 1. 

 (c) A change in the composition of the Company’s Board of Directors (the
“Board”) during any period of two consecutive years such that individuals who at the beginning of such period were members of the Board cease for any reason to constitute at least a majority thereof, unless the election, or
the nomination for election by the Company’s stockholders, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of the period; or 
 (d) Any person (as the term person is used in Section 13(d)(3) or Section 14(d)(2) of the Exchange Act of 1934, as
amended (the “Exchange Act”)) has become the beneficial owner (as the term “beneficial owner” is defined under Rule 13d-3, or any successor rule or regulation promulgated under the Exchange Act) of more than 50% of the then
outstanding voting securities of the Company; provided that changes in beneficial ownership resulting from issuances of securities by the Company in transactions the primary purpose of which is to raise capital through the sale of Company
equity to one or more financial investors shall be disregarded in determining whether a Change in Control has occurred. 
 3. Definition
of Good Reason. 
 For all purposes under this Agreement, “Good Reason” shall mean that the Employee: 

(a) Has been demoted or has incurred a material reduction in his authority or responsibility as an employee of the Company,
including (without limitation) a reduction or elimination of his authority to approve expenditures or to hire, promote, demote or terminate subordinates; 
 (b) Has incurred a reduction in his total compensation (including benefits) as an employee of the Company, other than pursuant to a Company-wide reduction of total compensation (including benefits) for
employees of the Company generally; 
 (c) Has not received a contemporaneous increase in his total compensation
(including benefits) which is commensurate with increases in total compensation (including benefits) received by a majority of executive-level employees of the Company with duties and responsibilities substantially comparable to those of the
Employee; 
 (d) Has not received a bonus commensurate with bonuses (if any) received by a majority of executive-level
employees of the Company with duties and responsibilities substantially comparable to those of the Employee; or 
 (e)
Has been notified that his principal place of work as an employee of the Company will be relocated by a distance of 50 miles or more. 
 4. Definition of Cause. 
 For all purposes under this Agreement, “Cause” shall mean: 
 (a) a material and continuing failure to perform the duties of Employee’s employment which is injurious to the Company, other
than a failure resulting from complete or partial incapacity due to physical or mental illness or impairment, which failure is not corrected within 15 business days after written notice thereof to the Employee; 
  

 2. 

 (b) Employee’s gross misconduct or fraud; or 
 (c) Employee’s conviction of, or plea of “guilty” or “no contest” to, a felony. 
 5. Definition of Continuation Period. 
 For all purposes under this Agreement, “Continuation Period” shall mean the period commencing on the date when the termination of the Employee’s employment under Section 6 is effective and ending on the
earlier of: 
 (a) The date six (6) months after the date when the employment termination was effective; or

 (b) The date of the Employee’s death. 
 6. Entitlement to Severance Pay and Benefits. 
 (a) The Employee shall be entitled to receive the severance pay described in Section 7 (the “Severance Pay”) and the benefits described in Section 8(a)(i), 8(b) and 8(c) from
the Company if on or before the occurrence of a Change in Control, the Company terminates the Employee’s employment for any reason other than Cause. 
 (b) The Employee shall be entitled to receive the Severance Pay described in Section 7 and the benefits described in Section 8(a)(ii), 8(b) and 8(c) from the Company if one of the following events
occurs: 
 (i) Within the first 12-month period after the occurrence of a Change in Control, the Employee voluntarily
resigns his employment for Good Reason; 
 (ii) Within the first 12-month period after the occurrence of a Change in
Control, the Company terminates the Employee’s employment for any reason other than Cause; or 
 (iii) Within the
first 12-month period after the occurrence of a Change in Control, the Company terminates the Employee’s employment because his position has been eliminated in connection with a restructuring or a reduction in force, as determined by the
Company. 
 (c) The Employee’s receipt of any Severance Pay or any other benefits pursuant to this Agreement shall
be subject to, and contingent upon, the Employee’s furnishing to the Company an effective Release and Waiver of Claims in the form attached hereto as Exhibit A. 
  

 3. 

 7. Amount of Severance Pay. During the Continuation Period, the Company shall pay the
Employee Severance Pay at an annual rate equal to the Employee’s base compensation at the annual rate in effect on the date 30 days prior to the date when the termination of his employment with the Company is effective. Such amount shall be
paid at periodic intervals in accordance with the Company’s standard payroll procedures. 
 8. Other Benefits. 
 (a) Stock Options and Restricted Stock. 
 (i) Immediately upon the occurrence of the event described in Section 6(a), there shall vest immediately such number of
unvested stock options and shares of restricted stock granted to Employee by the Company that would have vested if Employee’s employment would have continued for an additional 12 months following the occurrence of such event. 
 (ii) All unvested stock options and shares of restricted stock granted to Employee by the Company shall vest immediately upon the
occurrence of one of the events described in Section 6(b). 
 In the case of the foregoing clause (ii) only, the post-termination exercise grace
period under the Employee’s stock options shall commence at the end of the Continuation Period. The Employee represents that he has consulted or will consult a tax adviser regarding the impact of this Subsection (a) on the tax treatment of
Employee’s stock options and shares of restricted stock. 
 (b) Group Insurance. At the commencement of the
Continuation Period, the Employee (and, where applicable, his dependents) shall be entitled to convert his key employee long-term disability policy and group life insurance policy into individual policies pursuant to the terms of such policies.
Should the Employee elect to convert either or both of such policies, the Company will pay the premiums for such policy or policies during the Continuation Period. At the commencement of the Continuation Period, the Employee shall be eligible to
continue his group health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1986, and the Company will pay the premiums for such coverage during the Continuation Period. The foregoing notwithstanding, in the event
that the Employee becomes eligible for comparable group insurance coverage in connection with new employment, the premium payments by the Company under this Subsection (b) shall terminate immediately. 
 (c) Outplacement Services. If one of the events described in Section 6 has occurred, the Employee shall be entitled to
reasonable outplacement services at the Company’s expense. Such services shall be provided by a firm selected by the Employee from a list compiled by the Company and shall be limited to a period of six consecutive months. 
 9. Limitation on Payments. 
 (a) Reductions. If any payment or benefit Employee would receive in connection with a Change in Control from the Company or otherwise (a “Payment”) would (i) constitute a “parachute
payment” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code
(the “Excise Tax”), then such Payment shall be equal to the Reduced Amount (as defined below). The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no
portion of the Payment being subject to the Excise Tax or (y) the largest portion of the Payment, up to and including the total Payment, whichever amount, 

  

 4. 

 
after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable
marginal rate), results in the Employee’s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in payments or benefits
constituting “parachute payments” is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order unless the Employee elects in writing a different order (provided, however, that such
election shall be subject to Company approval if made on or after the date on which the event that triggers the Payment occurs): reduction of cash payments; cancellation of accelerated vesting of stock awards; reduction of employee benefits. If
acceleration of vesting of stock award compensation is to be reduced, such acceleration of vesting shall be cancelled in the reverse order of the date of grant of the Employee’s stock awards unless the Employee elects in writing a different
order for cancellation. 
 (b) Accounting Firm. The accounting firm engaged by the Company for general audit
purposes as of the day prior to the effective date of the Change in Control shall perform the foregoing calculations, subject to the necessary authorizations of the Audit Committee of the Company’s Board of Directors (the “Audit
Committee”). Alternatively, the Audit Committee may engage a consulting firm with expertise in calculations under Section 280G of the Code to perform such calculations. If any accounting firm so engaged by the Company is serving as
accountant or auditor for either the Employee or the entity or group that is effecting the Change in Control, the Company shall appoint a nationally recognized accounting or consulting firm to make the determinations required hereunder. The Company
shall bear all expenses with respect to the determinations by such accounting or consulting firm required to be made hereunder. 
 (c) Determinations. The accounting or consulting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and the Employee within ten
(10) calendar days after the date on which the Employee’s right to a Payment is triggered (if requested at that time by the Company or the Employee) or such other time as requested by the Company or the Employee. If the accounting or
consulting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and the Employee with an opinion reasonably acceptable to the Employee
that no Excise Tax will be imposed with respect to such Payment. Any good faith determinations of the accounting firm made hereunder shall be final, binding and conclusive upon the Company and the Employee. 
 10. Successors. 
 (a) Company’s Successors. The Company shall require any successor (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the
Company’s business and/or assets, by an agreement in substance and form satisfactory to the Employee, to assume this Agreement and to agree expressly to perform this Agreement in the same manner and to the same extent as the Company would be
required to perform it in the absence of a succession. For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement
described in this Subsection (a) or which becomes bound by this Agreement by operation of law. 
  

 5. 

 (b) Employee’s Successors. This Agreement and all rights of the
Employee hereunder shall inure to the benefit of, and be enforceable by, the Employee’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. 
 11. Application of Code Section 409A. If the Company determines that any severance benefit or payment under this Agreement fails to satisfy
the distribution requirement of Section 409A(a)(2)(A) of the Code as a result of Section 409A(a)(2)(B)(i) of the Code, the payment of such benefit shall be accelerated to the minimum extent necessary so that the benefit is not subject to
the provisions of Section 409A(a)(1) of the Code. (It is the intention of the preceding sentence to apply the short-term deferral provisions of Section 409A of the Code, and the regulations and other guidance thereunder, to any such
payments, and the payment schedule as revised after the application of the preceding sentence shall be referred to as the “Revised Payment Schedule”.) However, if there is no Revised Payment Schedule that would avoid the
application of Section 409A(a)(1) of the Code, the payment of such benefits shall not be paid pursuant to a Revised Payment Schedule and instead shall be delayed to the minimum extent necessary so that such benefits are not subject to the
provisions of Section 409A(a)(1) of the Code. The Company may attach conditions to or adjust the amounts paid under this Agreement to preserve, as closely as possible, the economic consequences that would have applied in the absence of this
Section 11; provided, however, that no such condition or adjustment shall result in the payments being subject to Section 409A(a)(1) of the Code. 
 12. Miscellaneous Provisions. 
 (a) Notice. Notices and all other
communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of
the Employee, mailed notices shall be addressed to him at the home address which he most recently communicated to the Company in writing. In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices
shall be directed to the attention of its Secretary. 
 (b) Waiver. No provision of this Agreement shall be
modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by the Employee and by an authorized officer of the Company (other than the Employee). No waiver by either party of any breach of, or of
compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 
 (c) Whole Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with
regard to the subject matter hereof, and supersede any and all prior agreements, representations or understandings (whether oral or written and whether express or implied) made or entered into by either party with respect to the subject matter
hereof, including without limitation the Prior Severance Agreement. 
  

 6. 

 (d) No Setoff; Withholding Taxes. There shall be no right of setoff or
counterclaim, with respect to any claim, debt or obligation against payments to the Employee under this Agreement. All payments made under this Agreement shall be subject to reduction to reflect taxes required to be withheld by law. 
 (e) Choice of Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the
laws of the State of California. 
 (f) Severability. The invalidity or unenforceability of any provision or
provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect. 
 (g) No Assignment. The rights of any person to payments or benefits under this Agreement shall not be made subject to option or assignment, either by voluntary or involuntary assignment or by operation
of law, including (without limitation) bankruptcy, garnishment, attachment or other creditor’s process, and any action in violation of this Subsection (g) shall be void. 
 (h) At-Will Employment; No Employment Rights. Employee acknowledges and agrees that Employee’s employment with the
Company is “at will,” and subject to the provisions of this Agreement, may be terminated at any time and for any reason whatsoever by Employee or the Company, with or without Cause and with or without advance notice. This
“at-will” employment relationship cannot be changed except in a writing signed by the Company’s Chief Executive Officer. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 7. 

 IN WITNESS WHEREOF, each of the parties has executed
this Agreement, in the case of the Company by its duly authorized officer, as of the Effective Date. 
  

	
	EMPLOYEE:
	
	/s/ BARRY GUMBINER
	Barry Gumbiner

  

			
	COMPANY:
	
	METABASIS THERAPEUTICS, INC.
		
	By	 	/s/ PAUL K. LAIKIND
	Title	 	Chief Executive Officer

 [SIGNATURE PAGE TO SEVERANCE
AGREEMENT] 

 EXHIBIT A 
 RELEASE AND WAIVER OF CLAIMS 
 (TO BE SIGNED FOLLOWING TERMINATION OF EMPLOYMENT) 

In consideration of the payments and other benefits set forth in the Severance Agreement dated June 18, 2007 (the
“Agreement”) to which this form is attached, I, Barry Gumbiner hereby furnish METABASIS THERAPEUTICS, INC. and any and all affiliated, subsidiary, related, or successor
corporations (collectively, the “Company”), with the following release and waiver (“Release and Waiver”). 
 In exchange for the consideration provided to me by the Agreement that I am not otherwise entitled to receive, I hereby generally and completely release and forever discharge the Company and its directors, officers,
employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees,
damages, indemnities and obligations of every kind and nature, in law, equity or otherwise, both known and unknown, suspected and unsuspected, disclosed and undisclosed, that arise out of or are in any way related to events, acts, conduct, or
omissions occurring prior to my signing this Release and Waiver. This general release includes, but is not limited to: (1) all claims arising out of or in any way related to my employment with the Company or the termination of that employment;
(2) all claims related to my compensation or benefits from the Company, including, but not limited to, salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other
ownership interests in the Company, other than as provided in the Agreement (and provided further that nothing in this general release shall affect (a) my right to receive a payout of my accrued but unused vacation and/or paid time off as of my
termination date or (b) my rights under any stock options or other stock awards granted, or under any written commitments regarding future grants of stock options or other stock awards approved, by the Company’s Board of Directors or the
Compensation Committee thereof prior to my termination date); (3) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including, but not limited
to, claims for fraud, emotional distress, and discharge in violation of public policy, related to my employment with the Company or the termination of that employment; and (5) all federal, state, and local statutory claims related to my
employment with the Company or the termination of that employment, including, but not limited to, claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as
amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”), and the California Fair Employment and Housing Act (as amended). 
 I also acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as follows: “A general release does
not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.” I hereby expressly waive and
relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to any claims I may have against the Company. 
  

 2. 

 I acknowledge and agree that, among other rights, I am waiving and releasing any rights I may have under
ADEA, that this Release and Waiver is knowing and voluntary, and that the consideration given for this Release and Waiver is in addition to anything of value to which I was already entitled as an executive of the Company. If I am 40 years of age or
older upon execution of this Release and Waiver, I further acknowledge that I have been advised, as required by the Older Workers Benefit Protection Act, that: (a) the release and waiver granted herein does not relate to claims under the ADEA
which may arise after this Release and Waiver is executed; (b) I should consult with an attorney prior to executing this Release and Waiver; (c) I have twenty-one (21) days in which to consider this Release and Waiver (although I may
choose voluntarily to execute this Release and Waiver earlier); (d) I have seven (7) days following the execution of this Release and Waiver to revoke my consent to this Release and Waiver; and (e) this Release and Waiver shall not be
effective until the eighth day after I execute this Release and Waiver and the revocation period has expired. 
 I acknowledge my continuing
obligations under my Employee Proprietary Information and Inventions Agreement with the Company (the “PIIA”) . 
 This Release and Waiver, along with the PIIA, constitutes the complete, final and exclusive embodiment of the entire agreement between the Company and me with regard to the subject matter hereof. I am not relying on any promise or
representation by the Company that is not expressly stated herein. This Release and Waiver may only be modified by a writing signed by both me and the Chief Executive Officer of the Company. 
  

									
					
	Date:	 	 	 		 	By:	 	 
					
		 		 		 	Print Name:	 	 

  

 3.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00156-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00156-of-00352.parquet"}]]